Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

elbasvir-grazoprevir drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
elbasvir-grazoprevir drug combination
Unique ID
C000611265
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000611265
Entry Term(s)
Zepatier
elbasvir grazoprevir drug combination
elbasvir, grazoprevir drug combination
Pharm Action
Antiviral Agents
Registry Numbers
0
Heading Mapped to
*Benzofurans
*Drug Combinations
*Imidazoles
*Quinoxalines
Frequency
62
Note
A combined pharmaceutical preparation of the antiviral agents elbasvir and grazoprevir that is used in the treatment of chronic HEPATITIS C viral infections in adult patients.
Source
Med Lett Drugs Ther. 2016 Feb 29;58(1489):25-7.
Date of Entry
2016/10/26
Revision Date
2016/10/05
elbasvir-grazoprevir drug combination Preferred
Zepatier Narrower
page delivered in 0.005s